In Prescription for the People, Fran Quigley diagnoses our inability to get medicines to the people who need them and then prescribes the cure. He delivers a clear and convincing argument for a complete shift in the global and U.S. approach to developing and providing essential medicines--and a primer on how to make that change happen. Globally...
In Prescription for the People, Fran Quigley diagnoses our inability to get medicines to the people who need them and then prescribes the cure. He delivers a clear and convincing argument for a complete shift in the global and U.S. approach to developing and providing essential medicines--and a primer on how to make that change happen. Globally...Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Fran Quigley is Clinical Professor and Director of the Health and Human Rights Clinic at Indiana University McKinney School of Law. He is the author of If We Can Win Here, also from Cornell, How Human Rights Can Build Haiti, and Walking Together, Walking Far. He is the cofounder of People of Faith for Access to Medicines, pfamrx.org.
Inhaltsangabe
Acknowledgments Introduction Part I 1. People Everywhere Are Struggling to Get the Medicines They Need 2. The United States Has a Drug Problem 3. Millions of People Are Dying Needlessly 4. Cancer Patients Face Particularly Deadly Barriers to Medicines 5. The Current Medicine System Neglects Many Major Diseases Part II 6. Corporate Research and Development Investments Are Exaggerated 7. The Current System Wastes Billions on Drug Marketing 8. The Current System Compromises Physician Integrity and Leads to Unethical Corporate Behavior 9. Medicines Are Priced at Whatever the Market Will Bear 10. Pharmaceutical Corporations Reap History-Making Pro ts Part III 11. The For-Profit Medicine Arguments Are Patently False 12. Medicine Patents Are Extended Too Far and Too Wide 13. Patent Protectionism Stunts the Development of New Medicines 14. Governments, Not Private Corporations, Drive Medicine Innovation 15. Taxpayers and Patients Pay Twice for Patented Medicines Part IV 16. Medicines Are a Public Good 17. Medicine Patents Are Arti cial, Recent, and Government-Created 18. The United States and Big Pharma Play the Bully in Extending Patents 19. Pharma-Pushed Trade Agreements Steal the Power of Democratically Elected Governments Part V 20. Current Law Provides Opportunities for Affordable Generic Medicines 21. There Is a Better Way to Develop Medicines 22. Human Rights Law Demands Access to Essential Medicines Conclusion Notes Index
Acknowledgments Introduction Part I 1. People Everywhere Are Struggling to Get the Medicines They Need 2. The United States Has a Drug Problem 3. Millions of People Are Dying Needlessly 4. Cancer Patients Face Particularly Deadly Barriers to Medicines 5. The Current Medicine System Neglects Many Major Diseases Part II 6. Corporate Research and Development Investments Are Exaggerated 7. The Current System Wastes Billions on Drug Marketing 8. The Current System Compromises Physician Integrity and Leads to Unethical Corporate Behavior 9. Medicines Are Priced at Whatever the Market Will Bear 10. Pharmaceutical Corporations Reap History-Making Pro ts Part III 11. The For-Profit Medicine Arguments Are Patently False 12. Medicine Patents Are Extended Too Far and Too Wide 13. Patent Protectionism Stunts the Development of New Medicines 14. Governments, Not Private Corporations, Drive Medicine Innovation 15. Taxpayers and Patients Pay Twice for Patented Medicines Part IV 16. Medicines Are a Public Good 17. Medicine Patents Are Arti cial, Recent, and Government-Created 18. The United States and Big Pharma Play the Bully in Extending Patents 19. Pharma-Pushed Trade Agreements Steal the Power of Democratically Elected Governments Part V 20. Current Law Provides Opportunities for Affordable Generic Medicines 21. There Is a Better Way to Develop Medicines 22. Human Rights Law Demands Access to Essential Medicines Conclusion Notes Index
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
